General Information of the Compound
Compound ID
CP0465194
Compound Name
8-[(3-Bromophenyl)amino]-1H-1,2,3-triazolo[4,5-g]-quinazoline
    Show/Hide
Structure
Formula
C14H9BrN6
Molecular Weight
341.172
Canonical SMILES
Brc1cccc(Nc2ncnc3cc4nn[nH]c4cc23)c1
    Show/Hide
InChI
InChI=1S/C14H9BrN6/c15-8-2-1-3-9(4-8)18-14-10-5-12-13(20-21-19-12)6-11(10)16-7-17-14/h1-7H,(H,16,17,18)(H,19,20,21)
    Show/Hide
InChIKey
VICIYGAOMIRRLW-UHFFFAOYSA-N
Physicochemical Property
logP
3.4072
Rotatable Bonds
2
Heavy Atom Count
21
Polar Areas
79.38
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 6419347
SID: 15722310
ChEMBL ID
CHEMBL172652
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000052 A-431 Homo sapiens (Human)  1
1
IC50 = 4.1 nM
   TI
   LI
   LO
   TS